Clinical Trial Update: Study Evaluating Neoadjuvant Immunotherapy Increasing CD8+ Cell Infiltration in Advance Gastric Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating neoadjuvant immunotherapy to increase CD8+ tumor-infiltrating lymphocytes in advanced gastric adenocarcinoma; status not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma

Snippet

Sponsor: Fujian Medical University | Conditions: Advanced Gastric Carcinoma, CD8+ Tumor Infiltrating Lymphocytes | Phase 3 | Status: NOT_YET_RECRUITING